Why Alnylam Pharmaceuticals, Intuitive Surgical, and ResMed Stocks Sank TodayThe Motley Fool • 03/12/20
ResMed (RMD) Down 3.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 02/29/20
ResMed Inc. (RMD) CEO Mick Farrell on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 01/31/20